nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadoversetamide—Laboratory test abnormal—Chenodeoxycholic acid—primary biliary cirrhosis	0.0193	0.0197	CcSEcCtD
Gadoversetamide—Laboratory test abnormal—Ursodeoxycholic acid—primary biliary cirrhosis	0.0193	0.0197	CcSEcCtD
Gadoversetamide—Gadoxetate—ABCC2—primary biliary cirrhosis	0.0182	1	CrCbGaD
Gadoversetamide—Creatine phosphokinase increased—Colchicine—primary biliary cirrhosis	0.0171	0.0174	CcSEcCtD
Gadoversetamide—Gastric ulcer—Ursodeoxycholic acid—primary biliary cirrhosis	0.0139	0.0141	CcSEcCtD
Gadoversetamide—Gastric ulcer—Chenodeoxycholic acid—primary biliary cirrhosis	0.0139	0.0141	CcSEcCtD
Gadoversetamide—Blood creatine phosphokinase increased—Colchicine—primary biliary cirrhosis	0.013	0.0133	CcSEcCtD
Gadoversetamide—Amblyopia—Ursodeoxycholic acid—primary biliary cirrhosis	0.0104	0.0106	CcSEcCtD
Gadoversetamide—Amblyopia—Chenodeoxycholic acid—primary biliary cirrhosis	0.0104	0.0106	CcSEcCtD
Gadoversetamide—Oliguria—Colchicine—primary biliary cirrhosis	0.00974	0.00992	CcSEcCtD
Gadoversetamide—Creatinine increased—Colchicine—primary biliary cirrhosis	0.00943	0.0096	CcSEcCtD
Gadoversetamide—Accidental injury—Chenodeoxycholic acid—primary biliary cirrhosis	0.00911	0.00928	CcSEcCtD
Gadoversetamide—Accidental injury—Ursodeoxycholic acid—primary biliary cirrhosis	0.00911	0.00928	CcSEcCtD
Gadoversetamide—Dysmenorrhoea—Chenodeoxycholic acid—primary biliary cirrhosis	0.00887	0.00903	CcSEcCtD
Gadoversetamide—Dysmenorrhoea—Ursodeoxycholic acid—primary biliary cirrhosis	0.00887	0.00903	CcSEcCtD
Gadoversetamide—Herpes simplex—Ursodeoxycholic acid—primary biliary cirrhosis	0.00875	0.00891	CcSEcCtD
Gadoversetamide—Herpes simplex—Chenodeoxycholic acid—primary biliary cirrhosis	0.00875	0.00891	CcSEcCtD
Gadoversetamide—Creatinine increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.00847	0.00863	CcSEcCtD
Gadoversetamide—Creatinine increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.00847	0.00863	CcSEcCtD
Gadoversetamide—Neck pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.00816	0.00831	CcSEcCtD
Gadoversetamide—Neck pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.00816	0.00831	CcSEcCtD
Gadoversetamide—Eructation—Chenodeoxycholic acid—primary biliary cirrhosis	0.00792	0.00807	CcSEcCtD
Gadoversetamide—Eructation—Ursodeoxycholic acid—primary biliary cirrhosis	0.00792	0.00807	CcSEcCtD
Gadoversetamide—Melaena—Ursodeoxycholic acid—primary biliary cirrhosis	0.00788	0.00802	CcSEcCtD
Gadoversetamide—Melaena—Chenodeoxycholic acid—primary biliary cirrhosis	0.00788	0.00802	CcSEcCtD
Gadoversetamide—Cramps of lower extremities—Ursodeoxycholic acid—primary biliary cirrhosis	0.00741	0.00754	CcSEcCtD
Gadoversetamide—Cramps of lower extremities—Chenodeoxycholic acid—primary biliary cirrhosis	0.00741	0.00754	CcSEcCtD
Gadoversetamide—Ecchymosis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00729	0.00742	CcSEcCtD
Gadoversetamide—Ecchymosis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00729	0.00742	CcSEcCtD
Gadoversetamide—Sleep disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00676	0.00689	CcSEcCtD
Gadoversetamide—Sleep disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00676	0.00689	CcSEcCtD
Gadoversetamide—Injury—Chenodeoxycholic acid—primary biliary cirrhosis	0.00637	0.00649	CcSEcCtD
Gadoversetamide—Injury—Ursodeoxycholic acid—primary biliary cirrhosis	0.00637	0.00649	CcSEcCtD
Gadoversetamide—Amnesia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00623	0.00634	CcSEcCtD
Gadoversetamide—Amnesia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00623	0.00634	CcSEcCtD
Gadoversetamide—Blood creatinine increased—Colchicine—primary biliary cirrhosis	0.0061	0.00622	CcSEcCtD
Gadoversetamide—Diplopia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00585	0.00596	CcSEcCtD
Gadoversetamide—Diplopia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00585	0.00596	CcSEcCtD
Gadoversetamide—Muscular weakness—Colchicine—primary biliary cirrhosis	0.00575	0.00585	CcSEcCtD
Gadoversetamide—Alanine aminotransferase increased—Colchicine—primary biliary cirrhosis	0.00575	0.00585	CcSEcCtD
Gadoversetamide—Face oedema—Ursodeoxycholic acid—primary biliary cirrhosis	0.00565	0.00575	CcSEcCtD
Gadoversetamide—Face oedema—Chenodeoxycholic acid—primary biliary cirrhosis	0.00565	0.00575	CcSEcCtD
Gadoversetamide—Blood creatinine increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.00548	0.00558	CcSEcCtD
Gadoversetamide—Blood creatinine increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.00548	0.00558	CcSEcCtD
Gadoversetamide—Alanine aminotransferase increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.00516	0.00526	CcSEcCtD
Gadoversetamide—Alanine aminotransferase increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.00516	0.00526	CcSEcCtD
Gadoversetamide—Asthma—Ursodeoxycholic acid—primary biliary cirrhosis	0.00506	0.00515	CcSEcCtD
Gadoversetamide—Influenza—Ursodeoxycholic acid—primary biliary cirrhosis	0.00506	0.00515	CcSEcCtD
Gadoversetamide—Influenza—Chenodeoxycholic acid—primary biliary cirrhosis	0.00506	0.00515	CcSEcCtD
Gadoversetamide—Dysphagia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00506	0.00515	CcSEcCtD
Gadoversetamide—Asthma—Chenodeoxycholic acid—primary biliary cirrhosis	0.00506	0.00515	CcSEcCtD
Gadoversetamide—Dysphagia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00506	0.00515	CcSEcCtD
Gadoversetamide—Haematuria—Colchicine—primary biliary cirrhosis	0.00479	0.00487	CcSEcCtD
Gadoversetamide—Dysuria—Ursodeoxycholic acid—primary biliary cirrhosis	0.00473	0.00482	CcSEcCtD
Gadoversetamide—Dysuria—Chenodeoxycholic acid—primary biliary cirrhosis	0.00473	0.00482	CcSEcCtD
Gadoversetamide—Pneumonia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00454	0.00462	CcSEcCtD
Gadoversetamide—Pneumonia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00454	0.00462	CcSEcCtD
Gadoversetamide—Hypoaesthesia—Colchicine—primary biliary cirrhosis	0.00448	0.00457	CcSEcCtD
Gadoversetamide—Urinary tract infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.00438	0.00447	CcSEcCtD
Gadoversetamide—Conjunctivitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00438	0.00447	CcSEcCtD
Gadoversetamide—Urinary tract infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.00438	0.00447	CcSEcCtD
Gadoversetamide—Conjunctivitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00438	0.00447	CcSEcCtD
Gadoversetamide—Haematuria—Ursodeoxycholic acid—primary biliary cirrhosis	0.0043	0.00438	CcSEcCtD
Gadoversetamide—Haematuria—Chenodeoxycholic acid—primary biliary cirrhosis	0.0043	0.00438	CcSEcCtD
Gadoversetamide—Epistaxis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00425	0.00433	CcSEcCtD
Gadoversetamide—Epistaxis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00425	0.00433	CcSEcCtD
Gadoversetamide—Sinusitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00423	0.00431	CcSEcCtD
Gadoversetamide—Sinusitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00423	0.00431	CcSEcCtD
Gadoversetamide—Eye disorder—Colchicine—primary biliary cirrhosis	0.00421	0.00429	CcSEcCtD
Gadoversetamide—Haemoglobin—Ursodeoxycholic acid—primary biliary cirrhosis	0.00407	0.00414	CcSEcCtD
Gadoversetamide—Haemoglobin—Chenodeoxycholic acid—primary biliary cirrhosis	0.00407	0.00414	CcSEcCtD
Gadoversetamide—Mediastinal disorder—Colchicine—primary biliary cirrhosis	0.00406	0.00414	CcSEcCtD
Gadoversetamide—Rhinitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00406	0.00413	CcSEcCtD
Gadoversetamide—Rhinitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00406	0.00413	CcSEcCtD
Gadoversetamide—Haemorrhage—Ursodeoxycholic acid—primary biliary cirrhosis	0.00405	0.00412	CcSEcCtD
Gadoversetamide—Haemorrhage—Chenodeoxycholic acid—primary biliary cirrhosis	0.00405	0.00412	CcSEcCtD
Gadoversetamide—Pharyngitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00402	0.00409	CcSEcCtD
Gadoversetamide—Pharyngitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00402	0.00409	CcSEcCtD
Gadoversetamide—Urinary tract disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.004	0.00407	CcSEcCtD
Gadoversetamide—Urinary tract disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.004	0.00407	CcSEcCtD
Gadoversetamide—Oedema peripheral—Chenodeoxycholic acid—primary biliary cirrhosis	0.00399	0.00406	CcSEcCtD
Gadoversetamide—Oedema peripheral—Ursodeoxycholic acid—primary biliary cirrhosis	0.00399	0.00406	CcSEcCtD
Gadoversetamide—Urethral disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00397	0.00404	CcSEcCtD
Gadoversetamide—Urethral disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00397	0.00404	CcSEcCtD
Gadoversetamide—Malnutrition—Colchicine—primary biliary cirrhosis	0.00392	0.004	CcSEcCtD
Gadoversetamide—Eye disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00378	0.00385	CcSEcCtD
Gadoversetamide—Eye disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00378	0.00385	CcSEcCtD
Gadoversetamide—Tinnitus—Ursodeoxycholic acid—primary biliary cirrhosis	0.00378	0.00384	CcSEcCtD
Gadoversetamide—Tinnitus—Chenodeoxycholic acid—primary biliary cirrhosis	0.00378	0.00384	CcSEcCtD
Gadoversetamide—Muscle spasms—Colchicine—primary biliary cirrhosis	0.00377	0.00384	CcSEcCtD
Gadoversetamide—Cardiac disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00376	0.00383	CcSEcCtD
Gadoversetamide—Cardiac disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00376	0.00383	CcSEcCtD
Gadoversetamide—Angiopathy—Ursodeoxycholic acid—primary biliary cirrhosis	0.00367	0.00374	CcSEcCtD
Gadoversetamide—Angiopathy—Chenodeoxycholic acid—primary biliary cirrhosis	0.00367	0.00374	CcSEcCtD
Gadoversetamide—Immune system disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00366	0.00372	CcSEcCtD
Gadoversetamide—Immune system disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00366	0.00372	CcSEcCtD
Gadoversetamide—Mediastinal disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00365	0.00372	CcSEcCtD
Gadoversetamide—Mediastinal disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00365	0.00372	CcSEcCtD
Gadoversetamide—Chills—Ursodeoxycholic acid—primary biliary cirrhosis	0.00363	0.0037	CcSEcCtD
Gadoversetamide—Chills—Chenodeoxycholic acid—primary biliary cirrhosis	0.00363	0.0037	CcSEcCtD
Gadoversetamide—Arrhythmia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00362	0.00368	CcSEcCtD
Gadoversetamide—Arrhythmia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00362	0.00368	CcSEcCtD
Gadoversetamide—Malnutrition—Ursodeoxycholic acid—primary biliary cirrhosis	0.00352	0.00359	CcSEcCtD
Gadoversetamide—Malnutrition—Chenodeoxycholic acid—primary biliary cirrhosis	0.00352	0.00359	CcSEcCtD
Gadoversetamide—Flatulence—Ursodeoxycholic acid—primary biliary cirrhosis	0.00347	0.00354	CcSEcCtD
Gadoversetamide—Flatulence—Chenodeoxycholic acid—primary biliary cirrhosis	0.00347	0.00354	CcSEcCtD
Gadoversetamide—Tension—Ursodeoxycholic acid—primary biliary cirrhosis	0.00346	0.00352	CcSEcCtD
Gadoversetamide—Tension—Chenodeoxycholic acid—primary biliary cirrhosis	0.00346	0.00352	CcSEcCtD
Gadoversetamide—Nervousness—Chenodeoxycholic acid—primary biliary cirrhosis	0.00342	0.00349	CcSEcCtD
Gadoversetamide—Nervousness—Ursodeoxycholic acid—primary biliary cirrhosis	0.00342	0.00349	CcSEcCtD
Gadoversetamide—Back pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.00341	0.00347	CcSEcCtD
Gadoversetamide—Back pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.00341	0.00347	CcSEcCtD
Gadoversetamide—Muscle spasms—Ursodeoxycholic acid—primary biliary cirrhosis	0.00339	0.00345	CcSEcCtD
Gadoversetamide—Muscle spasms—Chenodeoxycholic acid—primary biliary cirrhosis	0.00339	0.00345	CcSEcCtD
Gadoversetamide—Arthralgia—Colchicine—primary biliary cirrhosis	0.00334	0.0034	CcSEcCtD
Gadoversetamide—Myalgia—Colchicine—primary biliary cirrhosis	0.00334	0.0034	CcSEcCtD
Gadoversetamide—Ill-defined disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00327	0.00333	CcSEcCtD
Gadoversetamide—Ill-defined disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00327	0.00333	CcSEcCtD
Gadoversetamide—Malaise—Chenodeoxycholic acid—primary biliary cirrhosis	0.00318	0.00324	CcSEcCtD
Gadoversetamide—Malaise—Ursodeoxycholic acid—primary biliary cirrhosis	0.00318	0.00324	CcSEcCtD
Gadoversetamide—Vertigo—Ursodeoxycholic acid—primary biliary cirrhosis	0.00317	0.00323	CcSEcCtD
Gadoversetamide—Vertigo—Chenodeoxycholic acid—primary biliary cirrhosis	0.00317	0.00323	CcSEcCtD
Gadoversetamide—Syncope—Ursodeoxycholic acid—primary biliary cirrhosis	0.00316	0.00322	CcSEcCtD
Gadoversetamide—Syncope—Chenodeoxycholic acid—primary biliary cirrhosis	0.00316	0.00322	CcSEcCtD
Gadoversetamide—Shock—Colchicine—primary biliary cirrhosis	0.00315	0.00321	CcSEcCtD
Gadoversetamide—Nervous system disorder—Colchicine—primary biliary cirrhosis	0.00314	0.0032	CcSEcCtD
Gadoversetamide—Thrombocytopenia—Colchicine—primary biliary cirrhosis	0.00313	0.00319	CcSEcCtD
Gadoversetamide—Palpitations—Chenodeoxycholic acid—primary biliary cirrhosis	0.00311	0.00317	CcSEcCtD
Gadoversetamide—Palpitations—Ursodeoxycholic acid—primary biliary cirrhosis	0.00311	0.00317	CcSEcCtD
Gadoversetamide—Skin disorder—Colchicine—primary biliary cirrhosis	0.00311	0.00317	CcSEcCtD
Gadoversetamide—Loss of consciousness—Ursodeoxycholic acid—primary biliary cirrhosis	0.0031	0.00316	CcSEcCtD
Gadoversetamide—Loss of consciousness—Chenodeoxycholic acid—primary biliary cirrhosis	0.0031	0.00316	CcSEcCtD
Gadoversetamide—Cough—Chenodeoxycholic acid—primary biliary cirrhosis	0.00308	0.00313	CcSEcCtD
Gadoversetamide—Cough—Ursodeoxycholic acid—primary biliary cirrhosis	0.00308	0.00313	CcSEcCtD
Gadoversetamide—Convulsion—Chenodeoxycholic acid—primary biliary cirrhosis	0.00305	0.00311	CcSEcCtD
Gadoversetamide—Convulsion—Ursodeoxycholic acid—primary biliary cirrhosis	0.00305	0.00311	CcSEcCtD
Gadoversetamide—Hypertension—Ursodeoxycholic acid—primary biliary cirrhosis	0.00304	0.0031	CcSEcCtD
Gadoversetamide—Hypertension—Chenodeoxycholic acid—primary biliary cirrhosis	0.00304	0.0031	CcSEcCtD
Gadoversetamide—Arthralgia—Ursodeoxycholic acid—primary biliary cirrhosis	0.003	0.00306	CcSEcCtD
Gadoversetamide—Chest pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.003	0.00306	CcSEcCtD
Gadoversetamide—Arthralgia—Chenodeoxycholic acid—primary biliary cirrhosis	0.003	0.00306	CcSEcCtD
Gadoversetamide—Myalgia—Ursodeoxycholic acid—primary biliary cirrhosis	0.003	0.00306	CcSEcCtD
Gadoversetamide—Myalgia—Chenodeoxycholic acid—primary biliary cirrhosis	0.003	0.00306	CcSEcCtD
Gadoversetamide—Chest pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.003	0.00306	CcSEcCtD
Gadoversetamide—Hypotension—Colchicine—primary biliary cirrhosis	0.00299	0.00305	CcSEcCtD
Gadoversetamide—Unspecified disorder of skin and subcutaneous tissue—Chenodeoxycholic acid—primary biliary cirrhosis	0.00298	0.00304	CcSEcCtD
Gadoversetamide—Unspecified disorder of skin and subcutaneous tissue—Ursodeoxycholic acid—primary biliary cirrhosis	0.00298	0.00304	CcSEcCtD
Gadoversetamide—Discomfort—Chenodeoxycholic acid—primary biliary cirrhosis	0.00296	0.00302	CcSEcCtD
Gadoversetamide—Discomfort—Ursodeoxycholic acid—primary biliary cirrhosis	0.00296	0.00302	CcSEcCtD
Gadoversetamide—Dry mouth—Chenodeoxycholic acid—primary biliary cirrhosis	0.00293	0.00299	CcSEcCtD
Gadoversetamide—Dry mouth—Ursodeoxycholic acid—primary biliary cirrhosis	0.00293	0.00299	CcSEcCtD
Gadoversetamide—Musculoskeletal discomfort—Colchicine—primary biliary cirrhosis	0.00292	0.00297	CcSEcCtD
Gadoversetamide—Confusional state—Ursodeoxycholic acid—primary biliary cirrhosis	0.0029	0.00295	CcSEcCtD
Gadoversetamide—Confusional state—Chenodeoxycholic acid—primary biliary cirrhosis	0.0029	0.00295	CcSEcCtD
Gadoversetamide—Oedema—Ursodeoxycholic acid—primary biliary cirrhosis	0.00288	0.00293	CcSEcCtD
Gadoversetamide—Oedema—Chenodeoxycholic acid—primary biliary cirrhosis	0.00288	0.00293	CcSEcCtD
Gadoversetamide—Shock—Ursodeoxycholic acid—primary biliary cirrhosis	0.00283	0.00288	CcSEcCtD
Gadoversetamide—Shock—Chenodeoxycholic acid—primary biliary cirrhosis	0.00283	0.00288	CcSEcCtD
Gadoversetamide—Nervous system disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00282	0.00287	CcSEcCtD
Gadoversetamide—Nervous system disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00282	0.00287	CcSEcCtD
Gadoversetamide—Thrombocytopenia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00282	0.00287	CcSEcCtD
Gadoversetamide—Thrombocytopenia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00282	0.00287	CcSEcCtD
Gadoversetamide—Tachycardia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00281	0.00286	CcSEcCtD
Gadoversetamide—Tachycardia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00281	0.00286	CcSEcCtD
Gadoversetamide—Skin disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00279	0.00285	CcSEcCtD
Gadoversetamide—Skin disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00279	0.00285	CcSEcCtD
Gadoversetamide—Decreased appetite—Colchicine—primary biliary cirrhosis	0.00278	0.00283	CcSEcCtD
Gadoversetamide—Hyperhidrosis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00278	0.00283	CcSEcCtD
Gadoversetamide—Hyperhidrosis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00278	0.00283	CcSEcCtD
Gadoversetamide—Gastrointestinal disorder—Colchicine—primary biliary cirrhosis	0.00276	0.00282	CcSEcCtD
Gadoversetamide—Fatigue—Colchicine—primary biliary cirrhosis	0.00276	0.00281	CcSEcCtD
Gadoversetamide—Anorexia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00274	0.00279	CcSEcCtD
Gadoversetamide—Anorexia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00274	0.00279	CcSEcCtD
Gadoversetamide—Hypotension—Ursodeoxycholic acid—primary biliary cirrhosis	0.00269	0.00274	CcSEcCtD
Gadoversetamide—Hypotension—Chenodeoxycholic acid—primary biliary cirrhosis	0.00269	0.00274	CcSEcCtD
Gadoversetamide—Musculoskeletal discomfort—Chenodeoxycholic acid—primary biliary cirrhosis	0.00262	0.00267	CcSEcCtD
Gadoversetamide—Musculoskeletal discomfort—Ursodeoxycholic acid—primary biliary cirrhosis	0.00262	0.00267	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Colchicine—primary biliary cirrhosis	0.00262	0.00267	CcSEcCtD
Gadoversetamide—Insomnia—Ursodeoxycholic acid—primary biliary cirrhosis	0.0026	0.00265	CcSEcCtD
Gadoversetamide—Insomnia—Chenodeoxycholic acid—primary biliary cirrhosis	0.0026	0.00265	CcSEcCtD
Gadoversetamide—Paraesthesia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00258	0.00263	CcSEcCtD
Gadoversetamide—Paraesthesia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00258	0.00263	CcSEcCtD
Gadoversetamide—Dyspnoea—Ursodeoxycholic acid—primary biliary cirrhosis	0.00256	0.00261	CcSEcCtD
Gadoversetamide—Dyspnoea—Chenodeoxycholic acid—primary biliary cirrhosis	0.00256	0.00261	CcSEcCtD
Gadoversetamide—Somnolence—Ursodeoxycholic acid—primary biliary cirrhosis	0.00256	0.0026	CcSEcCtD
Gadoversetamide—Somnolence—Chenodeoxycholic acid—primary biliary cirrhosis	0.00256	0.0026	CcSEcCtD
Gadoversetamide—Urticaria—Colchicine—primary biliary cirrhosis	0.00254	0.00259	CcSEcCtD
Gadoversetamide—Dyspepsia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00253	0.00258	CcSEcCtD
Gadoversetamide—Dyspepsia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00253	0.00258	CcSEcCtD
Gadoversetamide—Abdominal pain—Colchicine—primary biliary cirrhosis	0.00253	0.00258	CcSEcCtD
Gadoversetamide—Decreased appetite—Chenodeoxycholic acid—primary biliary cirrhosis	0.0025	0.00255	CcSEcCtD
Gadoversetamide—Decreased appetite—Ursodeoxycholic acid—primary biliary cirrhosis	0.0025	0.00255	CcSEcCtD
Gadoversetamide—Gastrointestinal disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00248	0.00253	CcSEcCtD
Gadoversetamide—Gastrointestinal disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00248	0.00253	CcSEcCtD
Gadoversetamide—Fatigue—Ursodeoxycholic acid—primary biliary cirrhosis	0.00248	0.00253	CcSEcCtD
Gadoversetamide—Fatigue—Chenodeoxycholic acid—primary biliary cirrhosis	0.00248	0.00253	CcSEcCtD
Gadoversetamide—Constipation—Chenodeoxycholic acid—primary biliary cirrhosis	0.00246	0.00251	CcSEcCtD
Gadoversetamide—Pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.00246	0.00251	CcSEcCtD
Gadoversetamide—Pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.00246	0.00251	CcSEcCtD
Gadoversetamide—Constipation—Ursodeoxycholic acid—primary biliary cirrhosis	0.00246	0.00251	CcSEcCtD
Gadoversetamide—Feeling abnormal—Chenodeoxycholic acid—primary biliary cirrhosis	0.00237	0.00241	CcSEcCtD
Gadoversetamide—Feeling abnormal—Ursodeoxycholic acid—primary biliary cirrhosis	0.00237	0.00241	CcSEcCtD
Gadoversetamide—Hypersensitivity—Colchicine—primary biliary cirrhosis	0.00236	0.0024	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.00235	0.0024	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.00235	0.0024	CcSEcCtD
Gadoversetamide—Asthenia—Colchicine—primary biliary cirrhosis	0.0023	0.00234	CcSEcCtD
Gadoversetamide—Urticaria—Ursodeoxycholic acid—primary biliary cirrhosis	0.00229	0.00233	CcSEcCtD
Gadoversetamide—Urticaria—Chenodeoxycholic acid—primary biliary cirrhosis	0.00229	0.00233	CcSEcCtD
Gadoversetamide—Abdominal pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.00227	0.00232	CcSEcCtD
Gadoversetamide—Body temperature increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.00227	0.00232	CcSEcCtD
Gadoversetamide—Abdominal pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.00227	0.00232	CcSEcCtD
Gadoversetamide—Body temperature increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.00227	0.00232	CcSEcCtD
Gadoversetamide—Diarrhoea—Colchicine—primary biliary cirrhosis	0.00219	0.00223	CcSEcCtD
Gadoversetamide—Hypersensitivity—Chenodeoxycholic acid—primary biliary cirrhosis	0.00212	0.00216	CcSEcCtD
Gadoversetamide—Hypersensitivity—Ursodeoxycholic acid—primary biliary cirrhosis	0.00212	0.00216	CcSEcCtD
Gadoversetamide—Asthenia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00206	0.0021	CcSEcCtD
Gadoversetamide—Asthenia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00206	0.0021	CcSEcCtD
Gadoversetamide—Vomiting—Colchicine—primary biliary cirrhosis	0.00204	0.00207	CcSEcCtD
Gadoversetamide—Pruritus—Ursodeoxycholic acid—primary biliary cirrhosis	0.00204	0.00207	CcSEcCtD
Gadoversetamide—Pruritus—Chenodeoxycholic acid—primary biliary cirrhosis	0.00204	0.00207	CcSEcCtD
Gadoversetamide—Rash—Colchicine—primary biliary cirrhosis	0.00202	0.00206	CcSEcCtD
Gadoversetamide—Dermatitis—Colchicine—primary biliary cirrhosis	0.00202	0.00205	CcSEcCtD
Gadoversetamide—Headache—Colchicine—primary biliary cirrhosis	0.00201	0.00204	CcSEcCtD
Gadoversetamide—Diarrhoea—Ursodeoxycholic acid—primary biliary cirrhosis	0.00197	0.002	CcSEcCtD
Gadoversetamide—Diarrhoea—Chenodeoxycholic acid—primary biliary cirrhosis	0.00197	0.002	CcSEcCtD
Gadoversetamide—Dizziness—Chenodeoxycholic acid—primary biliary cirrhosis	0.0019	0.00194	CcSEcCtD
Gadoversetamide—Dizziness—Ursodeoxycholic acid—primary biliary cirrhosis	0.0019	0.00194	CcSEcCtD
Gadoversetamide—Nausea—Colchicine—primary biliary cirrhosis	0.0019	0.00194	CcSEcCtD
Gadoversetamide—Vomiting—Ursodeoxycholic acid—primary biliary cirrhosis	0.00183	0.00186	CcSEcCtD
Gadoversetamide—Vomiting—Chenodeoxycholic acid—primary biliary cirrhosis	0.00183	0.00186	CcSEcCtD
Gadoversetamide—Rash—Ursodeoxycholic acid—primary biliary cirrhosis	0.00181	0.00185	CcSEcCtD
Gadoversetamide—Rash—Chenodeoxycholic acid—primary biliary cirrhosis	0.00181	0.00185	CcSEcCtD
Gadoversetamide—Dermatitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00181	0.00185	CcSEcCtD
Gadoversetamide—Dermatitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00181	0.00185	CcSEcCtD
Gadoversetamide—Headache—Ursodeoxycholic acid—primary biliary cirrhosis	0.0018	0.00184	CcSEcCtD
Gadoversetamide—Headache—Chenodeoxycholic acid—primary biliary cirrhosis	0.0018	0.00184	CcSEcCtD
Gadoversetamide—Nausea—Chenodeoxycholic acid—primary biliary cirrhosis	0.00171	0.00174	CcSEcCtD
Gadoversetamide—Nausea—Ursodeoxycholic acid—primary biliary cirrhosis	0.00171	0.00174	CcSEcCtD
